NO302816B1 - 15-deoksyspergualinanaloger og deres anvendelse, samt mellomprodukt for fremstilling derav - Google Patents

15-deoksyspergualinanaloger og deres anvendelse, samt mellomprodukt for fremstilling derav

Info

Publication number
NO302816B1
NO302816B1 NO950664A NO950664A NO302816B1 NO 302816 B1 NO302816 B1 NO 302816B1 NO 950664 A NO950664 A NO 950664A NO 950664 A NO950664 A NO 950664A NO 302816 B1 NO302816 B1 NO 302816B1
Authority
NO
Norway
Prior art keywords
deoxy
pergualin
analogs
intermediates
preparation
Prior art date
Application number
NO950664A
Other languages
English (en)
Norwegian (no)
Other versions
NO950664L (no
NO950664D0 (no
Inventor
Patrice Renaut
Luc Lebreton
Patrick Dutartre
Philippe Derrepas
Soth Samreth
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9402125A external-priority patent/FR2716451B1/fr
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Publication of NO950664D0 publication Critical patent/NO950664D0/no
Publication of NO950664L publication Critical patent/NO950664L/no
Publication of NO302816B1 publication Critical patent/NO302816B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
NO950664A 1994-02-24 1995-02-22 15-deoksyspergualinanaloger og deres anvendelse, samt mellomprodukt for fremstilling derav NO302816B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9402125A FR2716451B1 (fr) 1994-02-24 1994-02-24 Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR9406706A FR2716452B1 (fr) 1994-02-24 1994-06-01 Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.

Publications (3)

Publication Number Publication Date
NO950664D0 NO950664D0 (no) 1995-02-22
NO950664L NO950664L (no) 1995-08-25
NO302816B1 true NO302816B1 (no) 1998-04-27

Family

ID=26230971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950664A NO302816B1 (no) 1994-02-24 1995-02-22 15-deoksyspergualinanaloger og deres anvendelse, samt mellomprodukt for fremstilling derav

Country Status (23)

Country Link
US (1) US5637613A (ko)
EP (1) EP0669316B1 (ko)
JP (1) JP2874839B2 (ko)
KR (1) KR100188991B1 (ko)
CN (1) CN1148378C (ko)
AT (1) ATE156117T1 (ko)
AU (1) AU691847B2 (ko)
CA (1) CA2143216C (ko)
CZ (1) CZ287985B6 (ko)
DE (1) DE69404624T2 (ko)
DK (1) DK0669316T3 (ko)
ES (1) ES2106480T3 (ko)
FI (1) FI950728A (ko)
FR (1) FR2716452B1 (ko)
GR (1) GR3025164T3 (ko)
HK (1) HK1000489A1 (ko)
HU (1) HUT70958A (ko)
NO (1) NO302816B1 (ko)
NZ (1) NZ270449A (ko)
RU (1) RU2113431C1 (ko)
SK (1) SK281058B6 (ko)
TW (1) TW317562B (ko)
UA (1) UA37217C2 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
US5985824A (en) * 1997-02-27 1999-11-16 Genzyme Corporation Methods and compositions for treating cystic fibrosis
US5834421A (en) * 1997-02-27 1998-11-10 Genzyme Corporation Methods and compositions for treating cystic fibrosis
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
DE19923961A1 (de) * 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen
JP5878172B2 (ja) * 2010-07-29 2016-03-08 ラボラトワール フルニエ エスアーエス 炎症性眼疾患の治療/予防用化合物
FR2963238B1 (fr) * 2010-07-29 2012-12-28 Fournier Lab Sa Derives de 15-desoxyspergualine pour le traitement et/ou la prevention des maladies inflammatoires oculaires

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤

Also Published As

Publication number Publication date
CZ50295A3 (en) 1995-10-18
FI950728A0 (fi) 1995-02-17
GR3025164T3 (en) 1998-02-27
SK281058B6 (sk) 2000-11-07
DK0669316T3 (da) 1998-03-09
HU9500556D0 (en) 1995-04-28
SK24795A3 (en) 1995-09-13
CN1148378C (zh) 2004-05-05
US5637613A (en) 1997-06-10
EP0669316A1 (fr) 1995-08-30
HUT70958A (en) 1995-11-28
JPH0841007A (ja) 1996-02-13
DE69404624T2 (de) 1998-02-05
JP2874839B2 (ja) 1999-03-24
EP0669316B1 (fr) 1997-07-30
DE69404624D1 (de) 1997-09-04
ATE156117T1 (de) 1997-08-15
AU691847B2 (en) 1998-05-28
RU2113431C1 (ru) 1998-06-20
CZ287985B6 (cs) 2001-03-14
KR950032097A (ko) 1995-12-20
HK1000489A1 (en) 1998-03-27
UA37217C2 (uk) 2001-05-15
FR2716452A1 (fr) 1995-08-25
NZ270449A (en) 1996-08-27
AU1028895A (en) 1995-08-31
CN1119191A (zh) 1996-03-27
NO950664L (no) 1995-08-25
CA2143216A1 (en) 1995-08-25
FR2716452B1 (fr) 1996-05-10
FI950728A (fi) 1995-08-25
KR100188991B1 (ko) 1999-06-01
ES2106480T3 (es) 1997-11-01
CA2143216C (en) 1999-04-13
TW317562B (ko) 1997-10-11
NO950664D0 (no) 1995-02-22
RU95102479A (ru) 1997-05-10

Similar Documents

Publication Publication Date Title
FR2518088B1 (fr) Nouveaux derives d'aminoacides, et leur application therapeutique
ATE139778T1 (de) Xanthinverbindungen
FI841181A (fi) Nya n-fenyl-n'-cykloalkylalkanoy- piperaziner och foerfarande foer deras framstaellning.
FI852806L (fi) 2-substituerade -1,3-propylidendifosfonatderivat och deras framstaellning.
CO5011087A1 (es) Antagonistas de receptores de vitronectina
NO302816B1 (no) 15-deoksyspergualinanaloger og deres anvendelse, samt mellomprodukt for fremstilling derav
SE8600017D0 (sv) New compound
FI862251A0 (fi) Spiro-imidazolidiner som inhibitorer foer aldosreduktas.
FR2597097B1 (fr) Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
ES2117003T3 (es) Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.
DE68917333T2 (de) Heterocyclische Verbindungen und Antiulkusmittel.
ATE58135T1 (de) 1,3-oxathianderivate.
ATE46347T1 (de) Immunostimulierende peptide.
DK0586344T3 (da) Oxazolidinforbindelser og deres anvendelse som lægemidler
ATE205189T1 (de) Benzolsulfonylamin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE3887426T2 (de) Eperisone als Hypotonikum.
CO4950545A1 (es) 3-piperidinoles y 3-piperidinonas sustituidos teniendo actividad inhibidora de proteasas